青蒿素：源自中草药园的发现。
Artemisinin: discovery from the Chinese herbal garden.
机构信息
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
出版信息
Cell. 2011 Sep 16;146(6):855-8. doi: 10.1016/j.cell.2011.08.024. Epub 2011 Sep 9.
Abstract
This year's Lasker DeBakey Clinical Research Award goes to Youyou Tu for the discovery of artemisinin and its use in the treatment of malaria--a medical advance that has saved millions of lives across the globe, especially in the developing world.
摘要
今年的拉斯克-德贝基临床医学研究奖授予屠呦呦，以表彰她发现青蒿素并将其用于治疗疟疾——这一医疗进步挽救了全球数百万人的生命，特别是在发展中国家。
相似文献
1
Artemisinin: discovery from the Chinese herbal garden.青蒿素：源自中草药园的发现。
Cell. 2011 Sep 16;146(6):855-8. doi: 10.1016/j.cell.2011.08.024. Epub 2011 Sep 9.
2
From branch to bedside: Youyou Tu is awarded the 2011 Lasker~DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria.从实验室到临床：屠呦呦因发现青蒿素可治疗疟疾而荣获2011年拉斯克~德巴基临床医学研究奖。
J Clin Invest. 2011 Oct;121(10):3768-73. doi: 10.1172/jci60887.
3
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素抗性
N Engl J Med. 2009 Oct 29;361(18):1807; author reply 1808. doi: 10.1056/NEJMc091737.
4
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素抗性
N Engl J Med. 2009 Oct 29;361(18):1807-8; author reply 1808.
5
Prevention and treatment of artemisinin-resistant falciparum malaria: update for international travellers.青蒿素耐药恶性疟的预防与治疗：国际旅行者最新指南
Wkly Epidemiol Rec. 2010 May 21;85(21):195-6.
6
Malaria resistance to non-artemisinin partner drugs: how to reACT.疟疾对非青蒿素类联合用药的耐药性：应对策略
Lancet Infect Dis. 2015 Jun;15(6):621-3. doi: 10.1016/S1473-3099(15)70080-0. Epub 2015 Apr 12.
7
Artemisinin (Qinghaosu): a mesmerizing drug that still puzzles.青蒿素：一种仍令人困惑的迷人药物。
Sci China Life Sci. 2015 Nov;58(11):1151-3. doi: 10.1007/s11427-015-4955-8.
8
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.印度东部出现对青蒿素耐药的恶性疟原虫疟疾的证据。
N Engl J Med. 2018 Nov 15;379(20):1962-1964. doi: 10.1056/NEJMc1713777.
9
[More artemisinin-resistant malaria in Thailand].[泰国出现更多抗青蒿素疟疾]
Tidsskr Nor Laegeforen. 2012 May 29;132(10):1223. doi: 10.4045/tidsskr.12.0529.
10
Artemisinin resistance in Plasmodium falciparum: what is it really?疟原虫对青蒿素的抗药性：它到底是什么？
Trends Parasitol. 2013 Jul;29(7):318-20. doi: 10.1016/j.pt.2013.05.002. Epub 2013 Jun 11.
引用本文的文献
1
Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential.青蒿：从抗疟传统到新出现的抗癌潜力
Theranostics. 2025 Jun 20;15(15):7346-7377. doi: 10.7150/thno.115414. eCollection 2025.
2
Investing in traditional medicine: leveraging evidence and innovative research to strengthen the fight against malaria in Nigeria.投资传统医学：利用证据和创新研究加强尼日利亚抗击疟疾的斗争。
Malar J. 2025 Jul 15;24(1):232. doi: 10.1186/s12936-025-05359-w.
3
Supercritical CO extraction of artemisinin from plant and the biotechnological production of artemisinin precursors: A dual-focus review.从植物中超临界二氧化碳萃取青蒿素及青蒿素前体的生物技术生产：双焦点综述
Biotechnol Notes. 2025 May 26;6:143-156. doi: 10.1016/j.biotno.2025.05.003. eCollection 2025.
4
The Beneficial Use of , Artemisinin, and Other Compounds in Animal Health.青蒿素及其他化合物在动物健康方面的有益用途。
Animals (Basel). 2025 May 8;15(10):1359. doi: 10.3390/ani15101359.
5
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.双氢青蒿素与维奈托克联合使用通过C-MYC/BCL-XL/MCL-1三联靶向增强急性髓系白血病的抗肿瘤作用。
Discov Oncol. 2025 Apr 9;16(1):496. doi: 10.1007/s12672-025-02242-7.
6
The role and application of bioinformatics techniques and tools in drug discovery.生物信息学技术和工具在药物发现中的作用与应用。
Front Pharmacol. 2025 Feb 13;16:1547131. doi: 10.3389/fphar.2025.1547131. eCollection 2025.
7
Ly6G Neutrophils and Interleukin-17 Are Essential in Protection against Rodent Malaria Caused by ANKA.Ly6G 中性粒细胞和白细胞介素-17 对于抵御由 ANKA 引起的啮齿类疟疾至关重要。
Research (Wash D C). 2024 Dec 19;7:0559. doi: 10.34133/research.0559. eCollection 2024.
8
Production of the antimalarial drug precursor amorphadiene by microbial terpene synthase-like from the moss Sanionia uncinata.利用来自蔓藓 Sanionia uncinata 的微生物萜烯合酶样蛋白生产抗疟药物前体阿莫达非尼。
Planta. 2024 Nov 20;260(6):145. doi: 10.1007/s00425-024-04558-0.
9
Scientific research and publications in health: aimed at the value of knowledge and solution-based approaches solucionática.健康领域的科学研究与出版物：旨在知识的价值以及基于解决方案的解决方法。 （注：原文中“solucionática”可能有误，推测应为“solution-based”，按此理解进行了翻译）
Rev Peru Med Exp Salud Publica. 2024 Oct 21;41(3):236-238. doi: 10.17843/rpmesp.2024.413.14277.
10
The influence of spatial distribution and transcriptional regulation of secondary metabolites on the bioactivities of (Japanese lady bell).次生代谢产物的空间分布和转录调控对（桔梗）生物活性的影响
Heliyon. 2024 Sep 13;10(18):e37898. doi: 10.1016/j.heliyon.2024.e37898. eCollection 2024 Sep 30.
本文引用的文献
1
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study.在推广经杀虫剂处理的蚊帐和青蒿素为基础的联合疗法后疟疾发病率和拟除虫菊酯类药物抗药性：一项纵向研究。
Lancet Infect Dis. 2011 Dec;11(12):925-32. doi: 10.1016/S1473-3099(11)70194-3. Epub 2011 Aug 17.
2
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.青蒿素抗疟原虫活性需要血红蛋白摄取和消化。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11405-10. doi: 10.1073/pnas.1104063108. Epub 2011 Jun 27.
3
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.合成臭氧化物药物候选物 OZ439 为单剂量治愈无并发症疟疾带来新希望。
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4400-5. doi: 10.1073/pnas.1015762108. Epub 2011 Feb 7.
4
Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control?非洲按蚊对拟除虫菊酯的抗药性：对疟疾控制有何影响？
Trends Parasitol. 2011 Feb;27(2):91-8. doi: 10.1016/j.pt.2010.08.004. Epub 2010 Sep 16.
5
Changes in the burden of malaria in sub-Saharan Africa.撒哈拉以南非洲疟疾负担的变化。
Lancet Infect Dis. 2010 Aug;10(8):545-55. doi: 10.1016/S1473-3099(10)70096-7. Epub 2010 Jul 14.
6
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
7
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.恶性疟原虫的遗传多样性与氯喹选择性清除
Nature. 2002 Jul 18;418(6895):320-3. doi: 10.1038/nature00813.
8
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.恶性疟原虫消化液泡跨膜蛋白PfCRT的突变及其在氯喹耐药性中作用的证据。
Mol Cell. 2000 Oct;6(4):861-71. doi: 10.1016/s1097-2765(05)00077-8.
9
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.甲氟喹、青蒿素和乙胺嘧啶-磺胺多辛治疗恶性疟患者的随机对照研究。
Lancet. 1984 Dec 15;2(8416):1360-1. doi: 10.1016/s0140-6736(84)92057-9.
10
Antimalarial activity of mefloquine and qinghaosu.甲氟喹和青蒿素的抗疟活性。
Lancet. 1982 Aug 7;2(8293):285-8. doi: 10.1016/s0140-6736(82)90268-9.
Zotero 插件